First Treatment for Breast Cancer with certain Inherited Gene Mutation

Sulaiman Naseer*

The U.S. Food and Drug Administration approved use of Lynparza (olaparib tablets) treat certain types of  breast cancer that have spread (metastasized) and whose tumors have a specific inherited (germline) genetic mutation, making it the first drug in its class (PARP inhibitor) approved to treat breast cancer.

Keywords:

Published on: Feb 15, 2018 Pages: 1-1

Full Text PDF Full Text HTML DOI: 10.17352/sjggt.000013
CrossMark Publons Harvard Library HOLLIS Search IT Semantic Scholar Get Citation Base Search Scilit OAI-PMH ResearchGate Academic Microsoft GrowKudos Universite de Paris UW Libraries SJSU King Library SJSU King Library NUS Library McGill DET KGL BIBLiOTEK JCU Discovery Universidad De Lima WorldCat VU on WorldCat